Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2301studies shown
Showing 25-36 of 2,301
Other study type icon
RecruitingNCT07592689

Study of DT120 for Major Depressive Disorder (Ascend)

This study is recruiting in the United States. It focuses on depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionOtherFrom 18 Years to 74 Years
Countries
United States
Sponsor
Definium Therapeutics US, Inc.
Condition
Depression
Drug study icon
RecruitingNCT07553637

ALTO-207 in Adults With Treatment-resistant Depression (TRD)

This study exists to compare options and see whether the medication ALTO-207 offers something meaningfully different. For people living with Depression, that matters because care needs to work in daily life, not just in theory.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 75 Years
Countries
United States, United Kingdom
Sponsor
Alto Neuroscience
Condition
Depression
Device study icon
RecruitingNCT04041479

Biomarker-guided rTMS for Treatment Resistant Depression

This study is looking at whether a digital support tool can help people with Treatment Resistant Depression or depression. Participants take part in a digital support tool and complete follow-up assessments.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 22 Years to 65 Years
Countries
United States
Sponsor
Weill Medical College of Cornell University
Condition
Depression
Drug study icon
RecruitingNCT06480201

Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression

This study is looking at whether Ketamine can help people with Healthy, depression, or Treatment Resistant Depression. Participants take part in Ketamine and complete follow-up assessments.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 21 Years to 45 Years
Countries
United States
Sponsor
Texas A&M University
Condition
Depression
Drug study icon
RecruitingNCT07076407

A Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)

This study is recruiting in the United States, in Finland, in Poland, .... It is testing azetukalner for depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 74 Years
Countries
United States, Finland, Poland, ...
Sponsor
Xenon Pharmaceuticals Inc.
Condition
Depression
Behavioral study icon
RecruitingNCT05630963

Beyond Monoamines: The Role of the Nociceptin/Orphanin FQ Receptor in Major Depression

This observational study is following people with depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 18 Years to 45 Years
Countries
United States
Sponsor
Mclean Hospital
Condition
Depression
Device study icon
RecruitingNCT04004169

Closed-Loop Deep Brain Stimulation for Major Depression

This study is looking at test a personalized approach to brain stimulation as an intervention for depression. Participants take part in a digital support tool and complete follow-up assessments.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDeviceFrom 22 Years to 70 Years
Countries
United States
Sponsor
Andrew Krystal
Condition
Depression
Behavioral study icon
RecruitingNCT05051618

Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis

This study is looking at whether POWER-MS can help people with Multiple Sclerosis or depression. Participants take part in POWER-MS and complete follow-up assessments.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 18 Years to 64 Years
Countries
United States
Sponsor
University of Illinois at Chicago
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.